Glyco-engineering ACE2 for Improved Potency as SARS-CoV-2 Decoy Receptor

Glyco-engineered Biologics

Glyco-engineering ACE2 for Improved Potency as SARS-CoV-2 Decoy Receptor
November 19, 2025
Glyco-engineering ACE2 for Improved Potency as SARS-CoV-2 Decoy Receptor

On Dec 20, 2021, Capraz et al. from spanning institutions such as the University of Natural Resources and Life Sciences (BOKU) in Austria, published a paper in the journal eLife, titled "Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor". The paper details a rational, structure-guided approach to enhance the neutralizing capability […]

Read More >
Categories
Recent Posts
Engineering <em>E. coli</em> for Enhanced Expression of Glycoconjugate VaccinesEngineering E. coli for Enhanced Expression of Glycoconjugate Vaccines
Glyco-engineering ACE2 for Improved Potency as SARS-CoV-2 Decoy ReceptorGlyco-engineering ACE2 for Improved Potency as SARS-CoV-2 Decoy Receptor
Modifying the Glycocalyx of Melanoma Cells <em>via</em> Metabolic GlycoengineeringModifying the Glycocalyx of Melanoma Cells via Metabolic Glycoengineering
Engineering <em>Escherichia coli</em> for Highly Efficient Production of Lacto-<em>N</em>-triose IIEngineering Escherichia coli for Highly Efficient Production of Lacto-N-triose II
  • twitter
Our Services
Useful Links
Get In Touch
Copyright © CD BioGlyco. All Rights Reserved.
Top